Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.

Neuro-oncology·2026
Same author

Generational variation and stabilization in resynthesized allotetraploid Brassica juncea derived from diploid progenitors B. rapa and B. nigra.

BMC plant biology·2026
Same author

Reconfigurable MIMO antenna for Sub-6 GHz 5G cognitive radio with machine learning based metaheuristic optimization.

Scientific reports·2026
Same author

Can natural killer cells cure leukemia?

Leukemia·2026
Same author

The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson's Disease Pathogenesis.

Molecular neurobiology·2026
Same author

Waste water remediation through ultrafast reduction of organic dyes, nitroaromatics, and nitrofuran antibiotics employing efficient multifunctional rGO/Ni-MOF composites.

RSC advances·2026

Related Experiment Video

Updated: Sep 12, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K

Multiplexed iPSC platform for advanced NK cell immunotherapies.

Akhilesh Kumar1, Colin Fischer2, Frank Cichocki1

  • 1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA.

Cell Reports. Medicine
|August 8, 2025
PubMed
Summary

Human pluripotent stem cells (PSCs) can be differentiated into natural killer (NK) cells for cancer immunotherapy. Advances in induced PSC (iPSC) editing and guided differentiation enhance NK cell therapies for diverse patient needs.

Keywords:
chimeric antigen receptorgene editinggenetic engineeringimmunotherapyinduced pluripotent stem cellsnatural killer cells

More Related Videos

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

16.9K
Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.2K

Related Experiment Videos

Last Updated: Sep 12, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

1.0K
Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs
09:02

Development, Expansion, and In vivo Monitoring of Human NK Cells from Human Embryonic Stem Cells hESCs and Induced Pluripotent Stem Cells iPSCs

Published on: April 23, 2013

16.9K
Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
06:53

Generation of Natural Killer Cells from Human Expanded Potential Stem Cells

Published on: January 13, 2023

3.2K

Area of Science:

  • Stem cell biology
  • Immunology
  • Biotechnology

Background:

  • Human pluripotent stem cells (PSCs) offer potential for cancer immunotherapy and blood cell production.
  • PSCs self-renew and differentiate into specialized cells, including cytotoxic lymphocytes.
  • Natural killer (NK) cells are promising for cancer immunotherapy due to their tumor-lysing capabilities.

Purpose of the Study:

  • To review advances in induced PSC (iPSC) editing and guided differentiation for NK cell immunotherapy.
  • To explore optimizing iPSCs as a source for NK cell therapeutics.
  • To evaluate iPSC-derived NK cell-based therapies and future genome-editing strategies.

Main Methods:

  • Review of recent literature on iPSC editing and guided differentiation.
  • Analysis of strategies for enhancing NK cell function (e.g., CAR engineering, checkpoint molecule deletion).
  • Evaluation of iPSC-derived NK cell therapeutic applications.

Main Results:

  • Advances in iPSC technology enable the development of NK cell immunotherapeutic products.
  • Genetic modifications can enhance the efficacy of NK cells against cancer and viral infections.
  • Optimized iPSCs provide a versatile source for broadening therapeutic options.

Conclusions:

  • iPSC-derived NK cells represent a significant advancement in cellular therapy for cancer.
  • Genome editing strategies hold promise for further improving NK cell-based immunotherapies.
  • This approach broadens therapeutic options and addresses diverse patient needs in oncology.